FR2867979B1 - Nouvelle application therapeutique d'un derive de la phenothiazine - Google Patents

Nouvelle application therapeutique d'un derive de la phenothiazine

Info

Publication number
FR2867979B1
FR2867979B1 FR0403203A FR0403203A FR2867979B1 FR 2867979 B1 FR2867979 B1 FR 2867979B1 FR 0403203 A FR0403203 A FR 0403203A FR 0403203 A FR0403203 A FR 0403203A FR 2867979 B1 FR2867979 B1 FR 2867979B1
Authority
FR
France
Prior art keywords
therapeutic application
novel therapeutic
phenothiazine derivative
phenothiazine
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0403203A
Other languages
English (en)
Other versions
FR2867979A1 (fr
Inventor
Bernadette Pignol
Jean Luc Puel
Serge Auvin
De Lassauniere Pierre Chabrier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsen Pharma SAS
Original Assignee
Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0403203A priority Critical patent/FR2867979B1/fr
Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS
Priority to CN2005800091391A priority patent/CN1933840B/zh
Priority to ES05744629T priority patent/ES2315868T3/es
Priority to PL05744629T priority patent/PL1732567T3/pl
Priority to PT05744629T priority patent/PT1732567E/pt
Priority to JP2007505576A priority patent/JP5066444B2/ja
Priority to CA002560988A priority patent/CA2560988A1/fr
Priority to DK05744629T priority patent/DK1732567T3/da
Priority to US10/594,960 priority patent/US7696197B2/en
Priority to AT05744629T priority patent/ATE410169T1/de
Priority to RU2006138035/15A priority patent/RU2377992C2/ru
Priority to DE602005010222T priority patent/DE602005010222D1/de
Priority to PCT/FR2005/000713 priority patent/WO2005092345A1/fr
Priority to EP05744629A priority patent/EP1732567B1/fr
Priority to ARP050101212A priority patent/AR048195A1/es
Publication of FR2867979A1 publication Critical patent/FR2867979A1/fr
Application granted granted Critical
Publication of FR2867979B1 publication Critical patent/FR2867979B1/fr
Priority to HK07106266.7A priority patent/HK1101545A1/xx
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
FR0403203A 2004-03-29 2004-03-29 Nouvelle application therapeutique d'un derive de la phenothiazine Expired - Fee Related FR2867979B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR0403203A FR2867979B1 (fr) 2004-03-29 2004-03-29 Nouvelle application therapeutique d'un derive de la phenothiazine
RU2006138035/15A RU2377992C2 (ru) 2004-03-29 2005-03-25 Применение производного фенотиазина для профилактики и/или лечения потери слуха
PL05744629T PL1732567T3 (pl) 2004-03-29 2005-03-25 Zastosowanie pochodnej fenotiazyny do zapobiegania i/lub leczenia utraty słuchu
PT05744629T PT1732567E (pt) 2004-03-29 2005-03-25 Utilização de um derivado da fenotiazina para a prevenção e/ou o tratamento da perda de audição
JP2007505576A JP5066444B2 (ja) 2004-03-29 2005-03-25 聴力損失を予防及び/又は治療するためのフェノチアジン誘導体の使用
CA002560988A CA2560988A1 (fr) 2004-03-29 2005-03-25 Utilisation d'un derive de la phenothiazine pour la prevention et/ou le traitement de la perte d'audition
DK05744629T DK1732567T3 (da) 2004-03-29 2005-03-25 Anvendelse af et phenothiazin-derivat til at forhindre og/eller behandle höretab
US10/594,960 US7696197B2 (en) 2004-03-29 2005-03-25 Use of a phenothiazine derivative for preventing and/or treating hearing loss
CN2005800091391A CN1933840B (zh) 2004-03-29 2005-03-25 吩噻嗪衍生物用于制备预防和/或治疗听力减退的药物的用途
ES05744629T ES2315868T3 (es) 2004-03-29 2005-03-25 Utilizacion de un derivado de la fenotiazina para la prevencion y/o el tratamiento de la perdida de audicion.
DE602005010222T DE602005010222D1 (de) 2004-03-29 2005-03-25 Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust
PCT/FR2005/000713 WO2005092345A1 (fr) 2004-03-29 2005-03-25 Utilisation d’un derive de la phenothiazine pour la prevention et/ou le traitement de la perte d’audition
EP05744629A EP1732567B1 (fr) 2004-03-29 2005-03-25 Utilisation d'un derive de la phenothiazine pour la prevention et/ou le traitement de la perte d'audition
AT05744629T ATE410169T1 (de) 2004-03-29 2005-03-25 Verwendung eines phenothiazin-derivats zur prävention und/oder behandlung von gerhörverlust
ARP050101212A AR048195A1 (es) 2004-03-29 2005-03-30 Uso de un derivado de fenotiazina para la prevencion y/o tratamiento de la perdida de audicion
HK07106266.7A HK1101545A1 (en) 2004-03-29 2007-06-12 Use of a phenothiazine derivative for preventing and/or treating hearing loss

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0403203A FR2867979B1 (fr) 2004-03-29 2004-03-29 Nouvelle application therapeutique d'un derive de la phenothiazine

Publications (2)

Publication Number Publication Date
FR2867979A1 FR2867979A1 (fr) 2005-09-30
FR2867979B1 true FR2867979B1 (fr) 2006-06-30

Family

ID=34947604

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0403203A Expired - Fee Related FR2867979B1 (fr) 2004-03-29 2004-03-29 Nouvelle application therapeutique d'un derive de la phenothiazine

Country Status (2)

Country Link
CN (1) CN1933840B (fr)
FR (1) FR2867979B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2898357B1 (fr) * 2006-03-07 2012-02-17 Scras Derives d'amidine et leurs applications a titre de medicament

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE318809T1 (de) * 1999-11-05 2006-03-15 Sod Conseils Rech Applic Heterocyclische verbindungen und ihre verwendung als medikamente
FR2816509B1 (fr) * 2000-11-15 2004-02-06 Sod Conseils Rech Applic Association d'inhibiteurs de calpaine et de piegeurs des formes reactives de l'oxygene

Also Published As

Publication number Publication date
CN1933840A (zh) 2007-03-21
FR2867979A1 (fr) 2005-09-30
CN1933840B (zh) 2010-12-15

Similar Documents

Publication Publication Date Title
CY2017048I1 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
MA28802B1 (fr) Utilisations therapeutiques d'inhibiteurs de rtp801
CY2018005I1 (el) Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης
NO20052914D0 (no) Terapeutiske forbindelser
DE60303147D1 (de) Neues 2-pyridylethylbenzamid-derivat
IS7714A (is) Lyfjasamsetningar úr módafíníl
DE60300560D1 (de) Manschette eines Blutdruckmessgeräts
IS2707B (is) Nýjar lyfjasamsetningar úr módafíníli
IL173145A (en) Use of a pak inhibitor for the production of a medicament for the treatment of a joint disease
FR2850042B1 (fr) Generateur d'efforts dynamiques a balourd
DE60326734D1 (de) Ligations-behandlungsgerät
NO20050183L (no) Farmasoytiske salter av reboxetin
FR2867979B1 (fr) Nouvelle application therapeutique d'un derive de la phenothiazine
ITTO20030243A1 (it) Procedimento per realizzare un segmento di un'opera
ITMI20041657A1 (it) "testa di filatura"
ITRM20030522A1 (it) Dispositivo di acquisizione dell'immagine di un tessuto
IS7581A (is) Lyfjasamsetning
FR2857401B1 (fr) Entretoise pour patte d'ancrage
ITMI20030312V0 (it) Cerniera per la connessione articolata di un elemento piastriforme adun elemento di supporto
DK1608381T3 (da) En sammensætnings nye terapeutiske anvendelse
FR2850862B1 (fr) Tete de massage par aspiration d'un pli cutane
FR2843304B1 (fr) Extraits de sangsues pour stents
FR2803522B1 (fr) Nouvelle application therapeutique de l'enoxaparine
HU0203985D0 (en) Use of a pharmaceutical composition for alleviating side effect of a disease
PT1467737E (pt) Composicao farmaceutica orodispersivel de piribedil

Legal Events

Date Code Title Description
CA Change of address
CD Change of name or company name
ST Notification of lapse

Effective date: 20141128